How to buy Seattle Genetics (SGEN) shares in the UK

Learn how to easily invest in Seattle Genetics shares.

Seagen Inc (SGEN) is a publicly traded biotechnology business based in the US. It opened the day at $148.42 after a previous close of $148.96. During the day the price has varied from a low of $146.75 to a high of $149.63. The latest price was $148.5 (25 minute delay). Seattle Genetics is listed on the NASDAQ and employs 2,675 staff. All prices are listed in US Dollars.

How to buy shares in Seattle Genetics

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: SGEN in this case.
  5. Research Seattle Genetics shares. The platform should provide the latest information available.
  6. Buy your Seattle Genetics shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 5x Seattle Genetics shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £3.04
£610.40 total
Capital at risk
IG Share Dealing logo £0 £250 £11.26
£618.62 total
Capital at risk
Freetrade logo £0 £1 £2.73
£610.10 total
Capital at risk
Fineco logo £0 No minimum £6.07
£613.44 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £18.02
£625.39 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.61
£607.97 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £17.10
£624.47 total
Capital at risk
Stake logo £0 £50 £3.04
£610.40 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £17.09
£624.46 total
Capital at risk

Full comparison of share dealing platforms

Seattle Genetics share price (NASDAQ:SGEN)

Use our graph to track the performance of SGEN stocks over time.

Seattle Genetics price performance over time

Historical closes compared with the last close of $148.5

1 week (2022-08-03) -15.14%
1 month (2022-07-08) -16.31%
3 months (2022-05-10) 23.26%
6 months (2022-02-10) 18.87%
1 year (2021-08-10) -5.31%
2 years (2020-08-10) -5.83%
3 years (2019-08-09) 93.16%
5 years (2017-08-10) 221.43%

Is it a good time to buy Seattle Genetics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

eToro Free Stocks

Invest in Seattle Genetics shares with 0% commission

  • Start investing from as little as $10
  • Pay no stamp duty on UK shares
  • Join 25 million users who trust their investments with eToro
Other fees apply. Capital at risk

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Seattle Genetics under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

PEG ratio

Seattle Genetics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 18.5286. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Seattle Genetics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Seattle Genetics.

Total ESG risk score

Seattle Genetics's total ESG risk: 29.88

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Seattle Genetics's overall score of 29.88 (as at 01/01/2019) is nothing to write home about – landing it in it in the 56th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Seattle Genetics is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Environmental score

Seattle Genetics's environmental score: 1.18/100

Seattle Genetics's environmental score of 1.18 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Seattle Genetics is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Social score

Seattle Genetics's social score: 23.34/100

Seattle Genetics's social score of 23.34 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Seattle Genetics is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Governance score

Seattle Genetics's governance score: 10.36/100

Seattle Genetics's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Seattle Genetics is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Environmental, social, and governance (ESG) summary

Seagen Inc was last rated for ESG on: 2019-01-01.

Total ESG score 29.88
Total ESG percentile 55.9
Environmental score 1.18
Environmental score percentile 5
Social score 23.34
Social score percentile 5
Governance score 10.36
Governance score percentile 5

Seattle Genetics shares at a glance

Information last updated 2021-07-09.
Previous close$148.96
Change %-0.3088%
Information last updated 2022-08-06.
52-week range$105.43 - $192.79
50-day moving average$164.414
200-day moving average$151.2222
Wall St. target price$183.43
Dividend yield$0 (0%)
Earnings per share (TTM)$-3.775

Do Seattle Genetics shares pay dividends?

We're not expecting Seattle Genetics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Share price volatility

Over the last 12 months, Seattle Genetics's shares have ranged in value from as little as $105.43 up to $192.79. A popular way to gauge a stock's volatility is its "beta".

SGEN.US volatility(beta: 0.57)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Seattle Genetics's is 0.5697. This would suggest that Seattle Genetics's shares are less volatile than average (for this exchange).

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site